New NATALEE 5-year sub-analysis data reinforce sustained reduction in distant disease-free survival in broadest population of EBC patients13 ...
استكشف الفرص مع نوفارتس أدناه.
Novartis heeft wereldwijd zowat 119.000 medewerkers waarvan er 2000 in België werken. Het aantrekken van getalenteerde mensen, hen ontwikkelen en behouden is van cruciaal belang voor ons. Daarmee ...
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical ...
ノバルティス ファーマ株式会社（本社：東京都港区、代表取締役社長：ジョンポール・プリシーノ）（以下「ノバルティス ファーマ」）は、日本の前立腺がんの治療経験に基づく視点を ...
Asciminib (Scemblix®) nun auch zur Behandlung erwachsener Patient*innen mit neu diagnostizierter CML zugelassen1Zulassung basiert auf Ergebnissen der Phase-III ...
Basel, November 20, 2025 – Novartis today rolled forward its mid-term guidance to 2025-2030 with a sales CAGR of +5-6% cc. The updated outlook will be featured at its Meet Novartis Management event in ...
ノバルティス ファーマ株式会社（本社：東京都港区、代表取締役社長：ジョンポール・プリシーノ、以下「ノバルティス ファーマ」）は、本日、眼科用血管内皮増殖因子（VEGF）阻害剤 ...
America is facing a growing epidemic of chronic disease. Many of the most common chronic conditions, like cardiovascular disease and cancer, are often treatable. Yet for too many people, access to ...
Sports have a universal appeal that transcends boundaries. Each weekend, the National Football League (NFL) ignites millions of passionate fans from across the country, demonstrating the deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback